dioscin has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X; Liu, K; Peng, J; Qi, M; Qi, Y; Sun, H; Tao, X; Wang, C; Xu, L; Xu, Y; Yin, L | 1 |
| Han, X; Liu, K; Ma, X; Peng, J; Qi, Y; Song, S; Tao, X; Xu, L; Xu, Y; Yin, L; Zhang, Y; Zhen, Y | 1 |
2 other study(ies) available for dioscin and Kidney Diseases
| Article | Year |
|---|---|
Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Caspase 3; Cell Line; Diosgenin; Humans; Kidney Diseases; Lipopolysaccharides; Male; Mice, Inbred C57BL; MicroRNAs; Myeloid Differentiation Factor 88; NF-kappa B; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Toll-Like Receptor 4 | 2016 |
Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Cytokines; Diosgenin; Doxorubicin; Glutathione Transferase; Heme Oxygenase (Decyclizing); Kidney; Kidney Diseases; Male; Molecular Docking Simulation; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear | 2017 |